TILS.L Gross Margin

The Gross Margin of Tiziana Life Sciences PLC (TILS.L) is 63.16%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

TILS.L Gross Margin - Historical Value

Date	Value
2020-12-31	63.16%

TILS.L Gross Margin - Peers Comparison

Ticker	Name	Value
ETX.L	E-Therapeutics PLC	100.00%
IMCR	Immunocore Holdings PLC	99.12%
SCLP.L	Scancell Holdings PLC	90.13%
ABC.L	Abcam PLC	71.12%
CMPS	Compass Pathways PLC	7775.20%
HPHA.DE	Heidelberg Pharma AG	74.01%
MDXH.BR	MDxHealth SA	51.74%
SLN.L	Silence Therapeutics PLC	3133.78%
VVY.AS	Vivoryon Therapeutics NV	85.42%
BINV.ST	BioInvent International AB	42.37%
GNS.L	Genus PLC	36.68%
SANION.ST	Saniona AB	85.03%
ALQGC.PA	Quantum Genomics SA	-14205.07%
OSE.PA	OSE Immunotherapeutics SA	100.00%
MYOV	Myovant Sciences Ltd	77.68%
SIGHT.PA	Gensight Biologics SA	188.37%
BCYC	Bicycle Therapeutics PLC	7775.20%
CNTA	Centessa Pharmaceuticals PLC	7775.20%
EGTX.ST	Egetis Therapeutics AB (publ)	74.84%
NANOV.OL	Nordic Nanovector ASA	7775.20%
ORY.MC	Oryzon Genomics SA	-4700.00%
ALBPS.PA	Biophytis SA	7775.20%
CANTA.ST	Cantargia AB	7775.20%
BVXP.L	Bioventix PLC	93.20%
FARN.L	Faron Pharmaceuticals Oy	95.19%
MAB.WA	Mabion SA	75.54%
ABVX.PA	Abivax SA	-19700.00%
ADAP	Adaptimmune Therapeutics PLC	99.96%
POXEL.PA	Poxel SA	0.05%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%
BGBIO.OL	Bergenbio ASA	100.00%
PCIB.OL	PCI Biotech Holding ASA	100.00%
OXB.L	Oxford Biomedica PLC	41.17%
VSC.DE	4Sc AG	97.20%
XBRANE.ST	Xbrane Biopharma AB	90.83%
ALSEN.PA	Sensorion SA	7775.20%
DMYD B.ST	Diamyd Medical AB	-10161.54%